Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA clearance for clinical study of Alferon N in relapsing-remitting MS

July 22, 2004

AGY Therapeutics licenses sigma receptor agonist compound from M's Science

July 22, 2004

NeuroSearch initiates phase II studies of NS-1209 for refractory status epilepticus

July 22, 2004

Transdermal lidocaine for the treatment of neuropathic sensory loss

July 21, 2004

Novel PARP inhibitors for the treatment of cerebral infarction

July 21, 2004

Novel therapeutic polyagent for Alzheimer's disease therapy

July 21, 2004

LY-411575 tested in novel animal model of Alzheimer's

July 21, 2004

Therapeutic benefits of mitoxantrone in multiple sclerosis

July 21, 2004

Preclinical efficacy in a task sensitive to Alzheimer's disease

July 20, 2004

Safinamide improves motor function in patients with Parkinson's disease

July 20, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...